MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 164 filers reported holding MIRATI THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.50 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $4,102,000 | +128.8% | 55,956 | +32.4% | 0.01% | +66.7% |
| Q4 2018 | $1,793,000 | -51.4% | 42,275 | -46.1% | 0.00% | +50.0% |
| Q3 2018 | $3,690,000 | +116.2% | 78,360 | +126.3% | 0.00% | 0.0% |
| Q2 2018 | $1,707,000 | +1322.5% | 34,633 | +49.9% | 0.00% | – |
| Q1 2017 | $120,000 | +34.8% | 23,097 | +22.9% | 0.00% | – |
| Q4 2016 | $89,000 | -6.3% | 18,786 | +30.1% | 0.00% | – |
| Q3 2016 | $95,000 | +5.6% | 14,438 | -12.3% | 0.00% | – |
| Q2 2016 | $90,000 | -74.4% | 16,467 | 0.0% | 0.00% | -100.0% |
| Q1 2016 | $352,000 | -32.3% | 16,467 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $520,000 | +4.4% | 16,467 | +13.8% | 0.00% | 0.0% |
| Q3 2015 | $498,000 | +9.5% | 14,465 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $455,000 | +35.8% | 14,465 | +26.5% | 0.00% | 0.0% |
| Q1 2015 | $335,000 | +76.3% | 11,439 | +11.5% | 0.00% | – |
| Q4 2014 | $190,000 | +5.6% | 10,258 | 0.0% | 0.00% | – |
| Q3 2014 | $180,000 | -12.2% | 10,258 | 0.0% | 0.00% | – |
| Q2 2014 | $205,000 | – | 10,258 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |